Pharmaceutical products | Tenderlake

Pharmaceutical products

Contract Value:
GBP 2B - 2B
Notice Type:
Contract award notice
Published Date:
25 April 2017
Closing Date:
Location(s):
UKC NORTH EAST (ENGLAND) (UK UNITED KINGDOM)
UKD NORTH WEST (ENGLAND) (UK UNITED KINGDOM)
UKE YORKSHIRE AND THE HUMBER (UK UNITED KINGDOM)
UKF EAST MIDLANDS (ENGLAND) (UK UNITED KINGDOM)
UKG WEST MIDLANDS (ENGLAND) (UK UNITED KINGDOM)
UKH EAST OF ENGLAND (UK UNITED KINGDOM)
UKI LONDON (UK UNITED KINGDOM)
UKJ SOUTH EAST (ENGLAND) (UK UNITED KINGDOM)
UKK SOUTH WEST (ENGLAND) (UK UNITED KINGDOM)
Description:

NHS Framework Agreement for Branded Pharmaceuticals — National

Offer reference number: CM/PHR/14/5445

Period of framework agreement: 1.5.2017 to 30.4.2019 plus an option to extend for up to 24 months.


NHS Framework Agreement for Branded Pharmaceuticals — Midlands and East of England

Products associated with the lots are listed on Document No. 06c of the Invitation to Offer. Each individual National Product Code (NPC) pack description in each of the regions (England, Midlands and East of England, North of England, South of England and London) is deemed to be a separate product for the application of the award criteria. There is no restriction on the number of products that bidders can offer for, or be awarded.

The framework agreement is intended for use by the Department of Health, Public

Health England and the NHS in England. The framework may also be used by private sector contractors and agents working on behalf of the above.


NHS Framework Agreement for Branded Pharmaceuticals — North of England

Products associated with the lots are listed on Document No. 06c of the Invitation to Offer. Each individual National Product Code (NPC) pack description in each of the regions (England, Midlands and East of England, North of England, South of England and London) is deemed to be a separate product for the application of the award criteria. There is no restriction on the number of products that bidders can offer for, or be awarded.

The framework agreement is intended for use by the Department of Health, Public

Health England and the NHS in England. The framework may also be used by private sector contractors and agents working on behalf of the above.


NHS Framework Agreement for Branded Pharmaceuticals — South of England

Products associated with the lots are listed on Document No. 06c of the Invitation to Offer. Each individual National Product Code (NPC) pack description in each of the regions (England, Midlands and East of England, North of England, South of England and London) is deemed to be a separate product for the application of the award criteria. There is no restriction on the number of products that bidders can offer for, or be awarded.

The framework agreement is intended for use by the Department of Health, Public

Health England and the NHS in England. The framework may also be used by private sector contractors and agents working on behalf of the above.


NHS Framework Agreement for Branded Pharmaceuticals — London

Products associated with the lots are listed on Document No. 06c of the Invitation to Offer. Each individual National Product Code (NPC) pack description in each of the regions (England, Midlands and East of England, North of England, South of England and London) is deemed to be a separate product for the application of the award criteria. There is no restriction on the number of products that bidders can offer for, or be awarded.

The framework agreement is intended for use by the Department of Health, Public

Health England and the NHS in England. The framework may also be used by private sector contractors and agents working on behalf of the above.

Awarded to:
For details of the awarded supplier, please see section VI.3, Runcorn (UK)
Download full details as .pdf
The Buyer:
Commercial Medicines Unit
CPV Code(s):
33600000 - Pharmaceutical products